You are viewing the site in preview mode

Skip to main content

Advertisement

Open Peer Review Reports for: The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
19 Apr 2017 Submitted Original manuscript
29 May 2017 Reviewed Reviewer Report - Jann-Yuan Wang
10 Jun 2017 Reviewed Reviewer Report - Rachel Thomson
5 Jul 2017 Author responded Author comments - Kazuma Yagi
Resubmission - Version 2
5 Jul 2017 Submitted Manuscript version 2
7 Jul 2017 Reviewed Reviewer Report - Jann-Yuan Wang
1 Aug 2017 Author responded Author comments - Kazuma Yagi
Resubmission - Version 3
1 Aug 2017 Submitted Manuscript version 3
Publishing
2 Aug 2017 Editorially accepted
9 Aug 2017 Article published 10.1186/s12879-017-2665-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement